PharmChem (PCHM) Short Interest Ratio & Short Volume

Short interest is the volume of PharmChem shares that have been sold short but have not yet been closed out or covered. As of November 15th, traders have sold 100 shares of PCHM short. Learn More on PharmChem's current short interest.

Here is how the short interest of companies compare to PharmChem: Enzo Biochem, Inc. (1.16%), American Shared Hospital Services (0.95%), Psychemedics Co. (1.25%), OpGen, Inc. (0.19%), BioNexus Gene Lab Corp. (0.64%), MDxHealth SA (0.20%), Fresh2 Group Limited (1.27%), Aclarion, Inc. (3.81%), Zicix Co. (0.02%), First Choice Healthcare Solutions, Inc. (0.00%),

As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($4.85 billion), Charter Communications, Inc. ($4.81 billion), International Paper ($2.96 billion), Cencora, Inc. ($2.40 billion), Paychex, Inc. ($2.38 billion), Lululemon Athletica Inc. ($2.05 billion), SoFi Technologies, Inc. ($2.03 billion), Live Nation Entertainment, Inc. ($1.93 billion), Onsemi ($1.82 billion), and Tractor Supply ($1.65 billion). View all of the most shorted stocks.

Short selling PCHM is an investing strategy that aims to generate trading profit from PharmChem as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for PharmChem occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of PCHM, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PCHM, twice per month. The most recent reporting period available is November, 15 2024.